Analyses of risk factors for OS in all 104 patients
| Parameter . | Univariate . | Multivariate . | ||
|---|---|---|---|---|
| Hazard ratio (95% CI) . | P . | Hazard ratio (95% CI) . | P . | |
| Older than 50 y | 2.27 (1.23-4.20) | .009 | — | — |
| High disease risk | 1.87 (1.03-3.40) | .04 | 1.92 (1.06-3.50) | .03 |
| Graft PB (vs BM) | 2.04 (0.91-4.61) | .08 | — | — |
| Unrelated donor | 0.71 (0.40-1.29) | .26 | — | — |
| HLA mismatch | 1.13 (0.61-2.10) | .70 | — | — |
| Conventional regimens | 0.74 (0.39-1.39) | .35 | — | — |
| Skin stage 3 or 4 at biopsy | 1.11 (0.57-2.15) | .76 | — | — |
| MT (> 100 CD8+ cells) | 1.10 (0.59-2.08) | .76 | — | — |
| MM (> 200 CD163+ cells) | 2.38 (1.27-4.49) | .006 | 2.45 (1.30-4.61) | .006 |
| Parameter . | Univariate . | Multivariate . | ||
|---|---|---|---|---|
| Hazard ratio (95% CI) . | P . | Hazard ratio (95% CI) . | P . | |
| Older than 50 y | 2.27 (1.23-4.20) | .009 | — | — |
| High disease risk | 1.87 (1.03-3.40) | .04 | 1.92 (1.06-3.50) | .03 |
| Graft PB (vs BM) | 2.04 (0.91-4.61) | .08 | — | — |
| Unrelated donor | 0.71 (0.40-1.29) | .26 | — | — |
| HLA mismatch | 1.13 (0.61-2.10) | .70 | — | — |
| Conventional regimens | 0.74 (0.39-1.39) | .35 | — | — |
| Skin stage 3 or 4 at biopsy | 1.11 (0.57-2.15) | .76 | — | — |
| MT (> 100 CD8+ cells) | 1.10 (0.59-2.08) | .76 | — | — |
| MM (> 200 CD163+ cells) | 2.38 (1.27-4.49) | .006 | 2.45 (1.30-4.61) | .006 |
— indicates not applicable.